Trademark Overview
On Monday, February 23, 2026, a trademark application was filed for IONIS with the United States Patent and Trademark Office. The USPTO has given the IONIS trademark a serial number of 99666317. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 30, 2026. This trademark is owned by Ionis Pharmaceuticals, Inc.. The IONIS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances, biological preparations and substances, therapeutic preparations and substances, namely, nucleic acid-targeted therapeutics; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Biological preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Therapeutic preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders
